LY2090314
If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk
Description: LY2090314, an effective GSK-3alpha/beta inhibitor (IC50: 1.5 nM/0.9 nM), may improve... more
Product information "LY2090314"
Description: LY2090314, an effective GSK-3alpha/beta inhibitor (IC50: 1.5 nM/0.9 nM), may improve the efficacy of platinum-based chemotherapy regimens. LY2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer. Target: GSK-3. Smiles: Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c4cnc5ccccn45)c(c1)c23)C(=O)N1CCCCC1. References: Brail LH, et al. J Clin Oncol, 2011, 29, abstr 3030.
| Supplier: | TargetMol |
| Supplier-Nr: | T1755 |
Properties
| Application: | GSK-3alpha / GSK-3beta inhibitor |
| MW: | 512.53 D |
| Formula: | C28H25FN6O3 |
Database Information
| CAS : | 603288-22-8| Matching products |
| KEGG ID : | K08822 | Matching products |
Handling & Safety
| Storage: | -20°C |
| Shipping: | +4°C (International: +4°C) |
| Signal Word: | Warning |
| GHS Hazard Pictograms: |
|
| H Phrases: | H302 |
| P Phrases: | P264, P270, P301+310, P330, P501 |
Caution
Our products are for laboratory research use only: Not for administration to humans!
Our products are for laboratory research use only: Not for administration to humans!
You will get a certificate here
Viewed